Characterizing the impact of lymph node metastases on the survival outcome for metastatic renal cell carcinoma patients treated with targeted therapies.
Kroeger, Nils
Characterizing the impact of lymph node metastases on the survival outcome for metastatic renal cell carcinoma patients treated with targeted therapies. [electronic resource] - European urology Sep 2015 - 506-15 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1873-7560
10.1016/j.eururo.2014.11.054 doi
Aged
Angiogenesis Inhibitors--therapeutic use
Antineoplastic Agents--therapeutic use
Bone Neoplasms--drug therapy
Carcinoma, Renal Cell--drug therapy
Databases, Factual
Diaphragm
Disease-Free Survival
Female
Humans
Kaplan-Meier Estimate
Kidney Neoplasms--drug therapy
Liver Neoplasms--drug therapy
Lymph Nodes--pathology
Lymphatic Metastasis
Male
Middle Aged
Neoplasm Metastasis
Prognosis
Proportional Hazards Models
Retroperitoneal Space
Survival Rate
TOR Serine-Threonine Kinases--antagonists & inhibitors
Vascular Endothelial Growth Factor A--antagonists & inhibitors
Characterizing the impact of lymph node metastases on the survival outcome for metastatic renal cell carcinoma patients treated with targeted therapies. [electronic resource] - European urology Sep 2015 - 506-15 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1873-7560
10.1016/j.eururo.2014.11.054 doi
Aged
Angiogenesis Inhibitors--therapeutic use
Antineoplastic Agents--therapeutic use
Bone Neoplasms--drug therapy
Carcinoma, Renal Cell--drug therapy
Databases, Factual
Diaphragm
Disease-Free Survival
Female
Humans
Kaplan-Meier Estimate
Kidney Neoplasms--drug therapy
Liver Neoplasms--drug therapy
Lymph Nodes--pathology
Lymphatic Metastasis
Male
Middle Aged
Neoplasm Metastasis
Prognosis
Proportional Hazards Models
Retroperitoneal Space
Survival Rate
TOR Serine-Threonine Kinases--antagonists & inhibitors
Vascular Endothelial Growth Factor A--antagonists & inhibitors